20+ years expertise in Med Chem.
Founder and Manager of Greenpharma
Is author of more than 50 scientific publications and 20 patents.

Senior international executive in Pharma industry with 30+ years experience in Europe, Middle East/Africa and Asia. Strong drive, able to manage complex situations. Excellent track record in performances, company transformation and customer culture program. Previous managing experience at Takeda, Nycomed, Roche, GSK, Abbott.

20+ years expertise in CNS pharmacology.
Founder of Key-Obs.

Research director at INSERM, head of the team « Physiopathology of dependence and relapse » Inserm unit 952/ CNRS UMR7224, Université Pierre et Marie Curie, Paris VI.
He is also President of scientific advisory board of MILDT. Member of scientific committee of the European Observatory of Drugs and Toxicomanies.
He is Laureate for the Prize of the European College of Neurospsychopharmacology (September 2009) for his work and new hypothesis of neurobiological mechanisms of addiction.

Ph. D. in Pharmacology and a Medical Doctor and has held a number of key positions in his over 30 year career in the pharmaceutical industry including :

• Professor at the CHU Pitié-Salpétrière(1971-1997).
• Manager of the International development at Sanofi -Synthelabo (1997-2003).
• Chief Scientific Officer France Sanofi Aventis (2003-2006).

He is currently working as a Consultant to industry since 2007.

Professor in Immunology and Biotechnology at the University of Montpellier (Faculty of Pharmaceutical sciences); has pioneered in France the transfer of innovation by bridging the gap between academic research and industry in the fields of drug discovery, diagnostic tests and biotechnology; former director of the department of Life sciences at CNRS; formerly with Sanofi Pharmaceutical Group; co-founder of two startup companies: Innodia and I2T; co-author of more than 140 scientific publications and patents; inventor of innovative worldwide marketed diagnostic tests.

Sylvain Yon, Ph.D. is the Deputy CEO of Theraclion (www.theraclion.com). In this role, he leads both the research & development efforts of the company and the business expansion on the Asian markets.

Sylvain Yon is a co-founder of Echosens, where he headed engineering activities until 2008. He then successfully handled the company’s acquisition by a major player in the Chinese health industry, before joining Theraclion. He is also the founder of several companies in the fields of acoustics and the Internet

14+ years of experience in clinical research.
Previous experience at Parexel, Onxeo, Danone Research, DBV Technologies